Freenome Presents Data Demonstrating the Importance of Clinical Test Performance and Screening Adherence on Colorectal Cancer Outcomes
This study suggests that earlier detection of colorectal neoplasia improves clinical outcomes and highlights the benefits of preventing CRC through adenoma detection and subsequent lifelong colonoscopy surveillance.\nThe second study emphasized the importance of screening test adherence and the time that elapses between screening tests (test interval) on clinical outcomes.
- This study suggests that earlier detection of colorectal neoplasia improves clinical outcomes and highlights the benefits of preventing CRC through adenoma detection and subsequent lifelong colonoscopy surveillance.\nThe second study emphasized the importance of screening test adherence and the time that elapses between screening tests (test interval) on clinical outcomes.
- This study indicated that imperfect adherence mimics delays in screening, with both resulting in worse outcomes.
- Freenome is also building a machine learning feedback loop with healthcare providers to leverage real-world data and improve patient care through early detection.
- Freenome is headquartered in South San Francisco, California.\nView source version on businesswire.com: https://www.businesswire.com/news/home/20210521005112/en/\n'